Aronne, Director of the Comprehensive Weight Control Center at Weill Cornell Medicine one of the leading obesity researchers in the country
(2022) Ketogenic Diet for Human Diseases: The Underlying Mechanisms and Potential for Clinical Implementations Szewczuk, M
One study reported 100% regrowth at 8 months (Pei et al., 2022, Frontiers)
Your prescribing doctor may recommend a slower titration schedule if you have existing eye disease
Reduced-frequency GLP-1 as a maintenance strategy: in this case series, patients who tapered from weekly semaglutide/tirzepatide to less frequent dosing maintained weight loss, body composition, and metabolic syndrome gains, supporting structured de-escalation to lower burden without sacrificing efficacy
Remember, early detection and treatment can make a significant difference.